Evidence map›Paper›PMID 41064886›Full record

ArticleThe FEBS journal2026

Exploring the influence of lid region residues on fatty acid selectivity in a lipase originating from Rhizopus oryzae.

Zehui Dong, Majid Haddad Momeni, Kim Olofsson, Eva Nordberg Karlsson

Abstract read
In one paragraph

Article in The FEBS journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Zehui DongBiotechnology, Department of Chemistry, Lund University, Sweden.ORCID 0000-0001-6750-5183
Majid Haddad MomeniAAK AB, Malmö, Sweden.
Kim OlofssonAAK AB, Malmö, Sweden.
Eva Nordberg KarlssonBiotechnology, Department of Chemistry, Lund University, Sweden.

Funding

Stiftelsen för Strategisk Forskning ID18-0089
6 · The paper itself

Abstract

Lipases are vital in modifying lipid substrates across industries such as food, cosmetics, and pharmaceuticals. Among their features, fatty acid selectivity is particularly important for industrial applications. Rhizopus oryzae lipase (ROL) stands out for its high selectivity and broad applicability. In this study, we engineered single-residue variants of ROL by targeting Ala89 and Phe95 in its lid region. Additionally, a lid-swap chimera was created by replacing ROL's 15-residue lid with that of the homologous lipase from Rhizomucor miehei (RML). These variants were expressed and characterized to assess changes in substrate selectivity. Our results highlight the lid's key role in determining fatty acid preference. Notably, mutating Phe95 to smaller residues (Ile or Ala) significantly increased selectivity toward medium-chain fatty acid (MCFA) esters. In contrast, substituting Ala89 with bulkier residues (Phe or Trp) reduced activity-except in the lid-swap variant. Interestingly, although the lid-swap variant contains Trp89, the surrounding smaller, non-conserved residues may alleviate steric hindrance. This chimera retained high activity but shifted its preference from MCFAs to long-chain fatty acids (LCFAs), a novel observation. Overall, the engineered variants exhibited distinct substrate preferences without compromising thermostability, suggesting their potential for tailored applications in food, nutrition, and cosmetic industries.

Indexed as

Fatty AcidsFungal ProteinsLipaseRhizopusRhizopus oryzaeAmino Acid SubstitutionModels, MolecularProtein EngineeringRhizomucorSubstrate SpecificityFatty AcidsFungal ProteinsLipaseenzyme thermostabilitylipase selectivitystructural modelingsubstrate dockingYarrowia lipolytica production

Identifiers

PMID41064886
PMCPMC12871902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.